, an Oral Pathobiont Associated with Colorectal Cancer, Epigenetically Reprograms Human Colonocytes
Overview
Authors
Affiliations
Recently, an intestinal dysbiotic microbiota with enrichment in oral cavity bacteria has been described in colorectal cancer (CRC) patients. Here, we characterize and investigate one of these oral pathobionts, the Gram-positive anaerobic coccus . We identified two phylotypes (A and B) exhibiting different phenotypes and adhesion capabilities. We observed a strong association of phylotype A with CRC, with its higher abundance in feces and in tumoral tissue compared with the normal homologous colonic mucosa, which was associated with a distinct methylation status of patients. By developing an hypoxic co-culture system of human primary colonic cells with anaerobic bacteria, we show that phylotype A alters the DNA methylation profile promoters of key tumor-suppressor genes, oncogenes, and genes involved in epithelial-mesenchymal transition. In colonic mucosa of CRC patients carrying phylotype A, we found similar DNA methylation alterations, together with significant enrichment of differentially expressed genes in pathways involved in inflammation, cell adhesion, and regulation of actin cytoskeleton, providing evidence of possible role in the carcinogenic process.
Han Q, Li J, Li Z, Aishajiang R, Yu D Mater Today Bio. 2025; 31:101601.
PMID: 40066079 PMC: 11891152. DOI: 10.1016/j.mtbio.2025.101601.
Navarro-Sanchez A, Nieto-Vitoria M, Lopez-Lopez J, Martinez-Crespo J, Navarro-Mateu F BMC Cancer. 2025; 25(1):395.
PMID: 40038641 PMC: 11881450. DOI: 10.1186/s12885-025-13770-4.
Darnindro N, Abdullah M, Sukartini N, Rumende C, Pitarini A, Nursyirwan S World J Gastroenterol. 2025; 31(7):100051.
PMID: 39991683 PMC: 11755252. DOI: 10.3748/wjg.v31.i7.100051.
Chen Y, Qin Y, Fan T, Qiu C, Zhang Y, Dai M Int J Biol Sci. 2025; 21(4):1497-1512.
PMID: 39990665 PMC: 11844286. DOI: 10.7150/ijbs.102742.
Proton Pump Inhibitors and Oral-Gut Microbiota: From Mechanism to Clinical Significance.
Zhang X, Li Q, Xia S, He Y, Liu Y, Yang J Biomedicines. 2024; 12(10).
PMID: 39457584 PMC: 11504961. DOI: 10.3390/biomedicines12102271.